Researchers uncover a survival mechanism in cancer cells

An international study led by scientists from the Crick Institute in London and the Hebrew University of Jerusalem revealed a survival mechanism in cancer cells that allows the disease to erupt again even after aggressive treatment. In a paper published in Science the researchers describe the mechanism by which cancer tumor cells become cancer stem cells that can sustain long-term growth.
When cancer develops, the generated cells are not uniform in their biological properties and contribute differently to tumor development. Only a small portion of cancer cells can form new tumors or metastases, and these are called "cancer stem cells." This disparity between tumor cells poses major challenges in understanding the nature of the tumor, its sensitivity to drugs, and planning an effective treatment that will eliminate all tumor cells.
"Many chemotherapy drugs leave a small amount of cancer stem cells that cause a renewed outbreak of the disease after a few years. It is therefore important to identify cancer stem cells in tumors and characterize the differences between the different tumor cells as the basis for detecting weak spots in the course of the development of the disease," explained Prof. Eran Meshorer, head of the Laboratory for stem cells and epigenetics in the Institute of Life Sciences and a member of the Edmond and Lily Safra Center for Brain Sciences (ELSC) of The Hebrew University of Jerusalem.
Cancer stem cells are not limited to the tumor itself and they are able to engage again in healthy environment and stimulate the disease. To study the characteristics of those unique cells, Prof. Meshorer and doctoral student Alva Biran from the Hebrew University teamed up with Dr. Paula Scaffidi and Christina Morales Torres from The Crick Institute in London. The international research team also included Dr. Ayelet Hashahar Cohen of the Hebrew University, Dr. Rotem Ben-Hamo and Professor Sol Efroni from Bar-Ilan University, and Dr. Tom Misteli from the National Cancer Institute, NIH.
The research team found that in a number of cancer types, those cancer stem cells lose one of their DNA packaging proteins -- H1.0. By binding to DNA, H1.0 silences the expression of the genes it binds to.
"We found that the disappearance of H1.0 is crucial for the cancer cells to remain immortal. To understand the mechanism of action, we mapped its interaction with DNA and found that it binds to the genes' regulatory regions. When H1.0 levels go down, the genes to which it binds can be activated. These genes, it turns out, are the ones which provide the cancer cell with its immortal potential," explained Prof. Meshorer.
The study is based on epigenetics -- a scientific field that investigates gene expression in DNA by switching genes on and off. In order to identify the cancer stem cells from other cells in the tumor, the research team studied epigenetic mechanisms that distinguish between the least-sorted cells, with endless division properties and a potential to create growth, and the more sorted cells which lack this ability.
The results showed an inverse relation between H1.0 and the division of cancer cells: "As the H1.0 levels fall, the greater the potential of uncontrolled division of cells. In contrast, high levels of the protein prevent this process. We found that the disappearance of protein H1.0 is characteristic of cancer stem cells and it is necessary to maintain the ability of partition and the potential for growth creation."
The discovery could open the door for medical intervention in cancer stem cells aimed at the restoration of high levels of H1.0 in all cancer cells. While further research is needed to understand the effectiveness of H1.0 protein in preventing the spread of cancer growth, this research advances significantly the study of the mechanisms of cancer stem cells and the relatively new epigenetic approach to cancer research.



for more information visit our product website:Buy Tadacip 20 mg Online 

Location: United States

Comments

Post a Comment

Popular posts from this blog

Cell of origin in childhood brain tumors affects susceptibility to therapy

The study is published in the journal  Cancer Research . The brain is composed mainly of two types of cells ; neurons and supportive cells called glial cells. Glioma are brain tumors that are similar to glial cells and in adults malignant glioma is the most common form of primary brain tumor. In children malignant glioma is relatively rare, but, as for adults, the prognosis is very poor, and of all childhood cancers malignant glioma is among the most lethal. Malignant glioma in children is much less studied than in adults and to improve the possibilities to find efficient drugs more knowledge and relevant disease models are needed. Also, most studies in the field have been focused on the genetics of the disease and there is a lack of knowledge about in which cell type the tumor has originated and how this particular cell type affects the properties of the tumor. This is exactly what the researchers have investigated in the present study where they have used mouse models of gl...
Read more

Taking miniature organs from lab to clinic

Image
Two fluorescent microscopy pictures of intestinal organoids rising in artificial hydrogels. Credit score: N. Gjorevski/EPFL EPFL scientists have developed a gel for rising miniaturized physique organs that can be utilized in medical diagnostics and drug improvement. Organoids are miniature organs that may be grown within the lab from an individual's stem cells. They can be utilized to mannequin ailments, and sooner or later may very well be used to check medicine and even exchange broken tissue in sufferers. However at present organoids are very troublesome to develop in a standardized and managed manner, which is essential to designing and utilizing them. EPFL scientists have now solved the issue by growing a patent-pending "hydrogel" that gives a totally controllable and tunable solution to develop organoids. The breakthrough is printed in  Nature . Organ...
Read more

This can be a methylated DNA molecule. DNA methylation performs an vital function for epigenetic gene regulation in improvement and most cancers. Credit score: Christoph Bock/CeMM     Scientists have established complete maps of the human epigenome, shedding gentle on how the physique regulates which genes are lively wherein cells. During the last 5 years, a worldwide consortium of scientists has established epigenetic maps of two,100 cell sorts. Inside this coordinated effort, the CeMM Analysis Heart for Molecular Drugs contributed detailed DNA methylation maps of the growing blood, opening up new views for the understanding and remedy of leukemia and immune ailments. One of many nice mysteries in biology is how the numerous completely different cell sorts that make up our our bodies are derived from a single cell and from one DNA sequence, or genome. Now we have discovered rather a lot from learning the human genome, however have solely partially unveiled the processes underlying cell willpower. The id of every cell kind is basically outlined by an instructive layer of molecular annotations on prime of the genome -- the epigenome -- which acts as a blueprint distinctive to every cell kind and developmental stage. Not like the genome the epigenome adjustments as cells develop and in response to adjustments within the surroundings. Defects within the components that learn, write, and erase the epigenetic blueprint are concerned in lots of ailments. The excellent evaluation of the epigenomes of wholesome and irregular cells will facilitate new methods to diagnose and deal with numerous ailments, and in the end result in improved well being outcomes. A set of 41 coordinated papers now revealed by scientists from throughout the Worldwide Human Epigenome Consortium (IHEC) sheds gentle on these processes, taking world analysis within the subject of epigenomics a serious step ahead. These papers symbolize the newest work of IHEC member tasks from Canada, the European Union, Germany, Japan, Singapore, South Korea, and america. Three of those papers have been coordinated by Christoph Bock at CeMM. The most recent examine from Christoph Bock's group, revealed at the moment within the journal Cell Stem Cell, charts the epigenetic panorama of DNA methylation in human blood. Led by CeMM scientists Matthias Farlik and Florian Halbritter along with Fabian Müller from Max Plank Institute for Informatics, this examine highlights the dynamic nature of the epigenome within the improvement of human blood. Our physique produces billions of blood cells every single day, which develop from a couple of thousand stem cells on the prime of a fancy hierarchy of blood cells. Utilizing the most recent sequencing and epigenome mapping expertise, Bock's group now unraveled a blueprint of blood improvement that's encoded within the DNA methylation patterns of blood stem cells and their differentiating progeny. This success was made potential by shut worldwide cooperation of European scientists: Blood donations of British volunteers have been sorted by cell kind by the group of Mattia Frontini on the College of Cambridge. These samples have been shipped to Austria, the place CeMM scientists carried out the epigenome mapping. All information have been then processed in Germany on the Max Plank Institute for Informatics and collectively analyzed by scientists at CeMM and on the Max Plank Institute for Informatics. The results of the mixed effort of Bock's group and lots of different members of IHEC is an in depth map of the human epigenome, just like a three-dimensional mountain panorama: The stem cells reside on the mountain prime, with valleys of mobile differentiation descending in lots of instructions. Because the cells differentiate, they choose considered one of a number of epigenetically outlined routes and comply with it downhill, ultimately arriving at one particular valley, similar to a specialised cell kind. Cells can not simply escape these valleys, which supplies robustness and safety in opposition to ailments such most cancers. Two different research by Christoph Bock's group have been revealed earlier this 12 months and showcase how researchers are looking for to make the most of epigenetic data for drugs. For example, sure routes of differentiation are jammed in leukemia, such that cells can now not attain their vacation spot and take unsuitable turns as an alternative. Surveillance of these cells by epigenetic exams can contribute to a extra exact prognosis of leukemia -- medical exams of this method are ongoing. "The epigenetic map of the human blood helps us perceive how leukemia develops and which cells drive the illness," says Christoph Bock. That is related to most cancers diagnostics and personalised drugs, and it supplies a compass for future efforts aiming to reprogram the epigenome of particular person cells, for instance by erasing vital epigenetic alterations from leukemia cells.

Study findings were published in the Nov. 17 online version of  Cell . Co-authors included Baoli Hu, Ph.D., senior research scientist, Y. Alan Wang, Ph.D., associate professor, and Ronald A. DePinho, M.D., professor, all of Cancer Biology, and Qianghu Wang Ph.D., Bioinformatics and Computational Biology. "The poor prognosis of glioblastoma relates to the near universal recurrence of tumors despite robust treatment including surgery, radiotherapy and chemotherapy," said Hu. "Our study shows the potential for a new therapeutic strategy based on targeting the mechanisms allowing glioma to re-grow aggressively in the brain." Hu and his colleagues developed a glioblastoma model to locate glioma stem cells, which, like all stem calls, have the ability to become other cell types. The researchers further found that the gene, WNT5A, when activated, allowed glioma stem cells to transition, leading to invasive tumor growth. "We uncovered a process by which glioma ...
Read more